TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 54 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $66,000 | -73.6% | 140,817 | -24.8% | 0.00% | – |
| Q1 2019 | $250,000 | -78.7% | 187,222 | -82.0% | 0.00% | -100.0% |
| Q4 2018 | $1,174,000 | +84.0% | 1,040,447 | +348.8% | 0.00% | – |
| Q3 2018 | $638,000 | -29.0% | 231,808 | -8.0% | 0.00% | – |
| Q2 2018 | $899,000 | -36.0% | 252,097 | -44.9% | 0.00% | -100.0% |
| Q1 2018 | $1,405,000 | +0.8% | 457,894 | +106.8% | 0.00% | 0.0% |
| Q4 2017 | $1,394,000 | +148.0% | 221,425 | +168.6% | 0.00% | – |
| Q3 2017 | $562,000 | -37.6% | 82,429 | -34.8% | 0.00% | -100.0% |
| Q2 2017 | $900,000 | -45.5% | 126,422 | -29.8% | 0.00% | 0.0% |
| Q1 2017 | $1,652,000 | +58.8% | 179,964 | -30.4% | 0.00% | 0.0% |
| Q4 2016 | $1,040,000 | -22.0% | 258,670 | -25.8% | 0.00% | 0.0% |
| Q3 2016 | $1,333,000 | -1.8% | 348,433 | +10.2% | 0.00% | 0.0% |
| Q2 2016 | $1,358,000 | -10.5% | 316,061 | -3.8% | 0.00% | 0.0% |
| Q1 2016 | $1,518,000 | +28.0% | 328,468 | +176.9% | 0.00% | 0.0% |
| Q4 2015 | $1,186,000 | +167.1% | 118,606 | +98.3% | 0.00% | – |
| Q3 2015 | $444,000 | -78.1% | 59,801 | +40.0% | 0.00% | -100.0% |
| Q2 2015 | $2,025,000 | -2.6% | 42,722 | -24.7% | 0.00% | 0.0% |
| Q1 2015 | $2,079,000 | +531.9% | 56,765 | +584.1% | 0.00% | – |
| Q4 2014 | $329,000 | -77.7% | 8,298 | -88.8% | 0.00% | -100.0% |
| Q3 2014 | $1,478,000 | +28.4% | 74,173 | -13.1% | 0.00% | 0.0% |
| Q2 2014 | $1,151,000 | +1727.0% | 85,390 | +1357.7% | 0.00% | – |
| Q1 2014 | $63,000 | +70.3% | 5,858 | +109.4% | 0.00% | – |
| Q4 2013 | $37,000 | -76.1% | 2,797 | -79.6% | 0.00% | – |
| Q3 2013 | $155,000 | – | 13,727 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,048,642 | $3,219,000 | 0.50% |
| Virtus ETF Advisers LLC | 130,920 | $402,000 | 0.35% |
| 683 Capital Management, LLC | 600,000 | $1,842,000 | 0.16% |
| Tekla Capital Management LLC | 859,322 | $2,638,000 | 0.10% |
| DOW CHEMICAL CO /DE/ | 65,000 | $200,000 | 0.07% |
| Alambic Investment Management, L.P. | 115,834 | $356,000 | 0.05% |
| A.R.T. Advisors, LLC | 262,896 | $807,000 | 0.03% |
| Candriam S.C.A. | 520,613 | $1,598,000 | 0.03% |
| Man Group plc | 1,674,341 | $5,140,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $2,870,000 | 0.02% |